A61L 27/3687
Characterised by the use of chemical agents in the treatment
Official title: {characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents}
A61L27/3687 (Characterised by the use of chemical agents in the treatment) appears on 907 US grants and 1,340 published applications in this corpus.
Search patents in A61L- Granted patents
- 907
- Published applications
- 1,340
- Assignees
- 613
- Inventors
- 2,276
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 0 | 0 |
| 1982 | 3 | 0 |
| 1983 | 5 | 0 |
| 1984 | 4 | 0 |
| 1985 | 1 | 0 |
| 1986 | 3 | 0 |
| 1987 | 5 | 0 |
| 1988 | 5 | 0 |
| 1989 | 4 | 0 |
| 1990 | 3 | 0 |
| 1991 | 1 | 0 |
| 1992 | 5 | 0 |
| 1993 | 4 | 0 |
| 1994 | 6 | 0 |
| 1995 | 4 | 0 |
| 1996 | 9 | 0 |
| 1997 | 9 | 0 |
| 1998 | 17 | 0 |
| 1999 | 23 | 0 |
| 2000 | 15 | 0 |
| 2001 | 20 | 9 |
| 2002 | 13 | 26 |
| 2003 | 19 | 43 |
| 2004 | 9 | 36 |
| 2005 | 21 | 28 |
| 2006 | 15 | 22 |
| 2007 | 8 | 32 |
| 2008 | 9 | 19 |
| 2009 | 9 | 20 |
| 2010 | 18 | 20 |
| 2011 | 15 | 26 |
| 2012 | 16 | 30 |
| 2013 | 14 | 40 |
| 2014 | 39 | 68 |
| 2015 | 37 | 64 |
| 2016 | 39 | 75 |
| 2017 | 36 | 65 |
| 2018 | 43 | 76 |
| 2019 | 49 | 86 |
| 2020 | 71 | 87 |
| 2021 | 49 | 108 |
| 2022 | 41 | 86 |
| 2023 | 47 | 65 |
| 2024 | 53 | 78 |
| 2025 | 56 | 87 |
| 2026 | 31 | 44 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Lamellar corneal autologous or homologous graft in refractive surgery22 Sep 2026US 12,740,854 B2
- Methods of bioengineering internal anal sphincter constructs22 Sep 2026US 12,741,058 B2Wake Forest University Health Sciences
- Decellularized nerve graft and method of manufacturing the same1 Sep 2026US 12,721,930 B2L&C Bio Co., Ltd.
- Acellular dermal matrix for skin and surgical reconstruction and methods of making same28 Jul 2026US 12,691,202 B1Humabiologics, Inc.
- Regenerative tissue and natural tissue implants21 Jul 2026US 12,685,802 B2Vascudyne, Inc.
- Ordered collagen scaffold material, preparation method therefor, and use thereof8 Oct 2026US 2026/0306709 A1Db Wuderegen Biomedical Technologies (Jiang Su) Co., Ltd
- Application of stem cells or transgenic stem cells8 Oct 2026US 2026/0306716 A1Anhui Longhui Stem Cell Biotechnology Co., Ltd
- Intestinal tissue enhanced with therapeutic salts1 Oct 2026US 2026/0295122 A1Avalon Medical, Ltd.
- Devices and methods for preparing and conditioning biological assemblies for minimally invasive delivery for tissue engineering, cell therapies and other therapeutic applications1 Oct 2026US 2026/0295123 A1Volumina Medical SA
- Decellularized, delipidated tissues, hydrogels thereof, and uses thereof24 Sep 2026US 2026/0284262 A1
Most cited
By later US patents
- Method for repairing cartilage669US 5,842,477 AAdvanced Tissue Sciences, Inc. · 1998
- Method for processing and preserving collagen-based tissues for transplantation610US 5,336,616 ALifeCell Corporation · 1994
- Resorbable implant materials587US 6,312,474 B1Bio-Vascular, Inc. · 2001
- Compliant dehydrated tissue for implantation and process of making the same526US 6,277,555 B1The International Heart Institute of Montana Foundation · 2001
- Tissue repair fabric516US 5,733,337 AOrganogenesis, Inc. · 1998